QR Code

Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of Steatosis

In HCV-coinfected people with HIV (PWH), there are still conflicting data regarding the long-term metabolic impact of HCV eradication. The aim of the study is to investigate long-term changes in controlled attenuation parameter (CAP) and metabolic profile after sustained virological response (SVR) p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alessia Siribelli, Sara Diotallevi, Laura Galli, Camilla Muccini, Giulia Morsica, Riccardo Lolatto, Tommaso Clemente, Emanuela Messina, Costanza Bertoni, Caterina Uberti-Foppa, Antonella Castagna, Hamid Hasson
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Viruses
Subjects:	HCV HIV CAP DAAs steatosis SVR
Online Access:	https://www.mdpi.com/1999-4915/17/7/906
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of HCV eradication by directly acting antivirals on glycemic indices in chronic hepatitis C patients -a nationwide Taiwan HCV registry
by: Tyng-Yuan Jang, et al.
Published: (2025-08-01)

Real-Life Experiences with Telaprevir in the Treatment of Chronic Genotype 1 Hepatitis C — The TEPS Study
by: T. Berg, et al.
Published: (2019-01-01)

Genetic diversity of hepatitis C virus and the prevalence of resistance mutations to NS5A inhibitors in the Krasnoyarsk region
by: V. E. Ekushov, et al.
Published: (2024-04-01)

The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study
by: Juferdy Kurniawan, et al.
Published: (2019-08-01)

The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study
by: Juferdy Kurniawan, et al.
Published: (2019-08-01)

Liver steatosis in brain death donors
by: D. V. Voronov, et al.
Published: (2021-04-01)

Modern ultrasonic methods of diagnostics of hepatic steatosis
by: A. S. Kuznetsova, et al.
Published: (2023-08-01)

Evaluation of Hepatic Steatosis Grades with Thermoacoustic Imaging in a Rabbit Model
by: Xiang Hongjin, Huang Lin, Zheng Zhu, Li Jiawu, Qiu Tingting, Wu Zhenru, Shi Yujun, Jiang Huabei, Ling Wenwu, Luo Yan
Published: (2025-06-01)

Positive and linear association of hepatic steatosis index with female infertility in US women: results from the National Health and Nutrition Examination Survey 2013–2018
by: Xinjie Wu, et al.
Published: (2025-06-01)

Predictors of hepatic steatosis in living liver donors
by: M. G. Minina, et al.
Published: (2022-12-01)

ERADICATION OF HCV INFECTION IN PATIENTS WITH LIVER CIRRHOSIS: FACTOR OF CANCER PREVENTION OR CARCINOGENESIS?
by: N. A. Malinina, et al.
Published: (2019-06-01)

Interplatform Agreement Between Liver Steatosis Analysis and Ultrasound-Guided Attenuation Parameter in the Evaluation of Hepatic Steatosis
by: Chen J, et al.
Published: (2025-07-01)

Role of IL6 –174C/G gene polymorphism in development of chronic HCV infection
by: N. A. Semyonova, et al.
Published: (2010-10-01)

PERSPECTIVES OF TREATMENT OF TERMINAL LIVER DISEASE IN CHRONIC HCV-INFECTION
by: E. N. German, et al.
Published: (2010-06-01)

HBV, HCV, and HDV Triple-Infection—A Therapeutic Challenge
by: Alexia Anastasia Stefania Balta, et al.
Published: (2025-05-01)

State and prospects of therapeutic treatment of children with chronic hepatitis C in the Russian Federation
by: A. A. Fomicheva, et al.
Published: (2021-03-01)

Detection rate of specific antibodies to the HCV CORE+1 protein in “naive” cronically HCV-infected patients in depends on the stage of liver fibrosis and the HCV subtype
by: E. V. Lichnaya, et al.
Published: (2021-01-01)

Monitoring air quality index with EWMA and individual charts using XGBoost and SVR residuals
by: Zulfani Alfasanah, et al.
Published: (2025-06-01)

Role of Interleukin-28B in clearance of HCV in acute and chronic hepatitis patients in Kirkuk city
by: Muhannad Abdullah Alazzawy
Published: (2018-07-01)

Features of clinical course of chronic hepatites of mixed viral (HBV+HCV) etiologies
by: G. K. Mirodzhov, et al.
Published: (2009-10-01)

Multiparametric ultrasound liver examination in cardiological overweight patients: determining the cause of fibrosis and severity of steatosis
by: D. Yu. Shestakova, et al.
Published: (2025-02-01)

Metabolic mechanism of hepatic steatosis affecting production performance of dairy cows during peak lactation
by: LIU Xiaoyi, et al.
Published: (2024-10-01)

Diagnostic markers of hepatic steatosis in patients with chronic viral hepatitis C
by: V. V. Tsvetkov, et al.
Published: (2023-05-01)

The use of biomarkers GP-73 and AFP in the early diagnosis of hepatocarcinoma associated with liver cirrhosis of HCV etiology
by: A. K. Bayjanov, et al.
Published: (2025-06-01)

cfDNA Key genomic markers in HCV-Induced hepatocellular carcinoma in Egyptian patients
by: Mohamed Khalifa, et al.
Published: (2025-09-01)

The comparative description of clinical course, injury an regeneration of liver while chronic HBV- and HCV- infections course
by: V. E. Karev, et al.
Published: (2014-09-01)

Long non-coding RNA NEAT1 promotes steatosis via enhancement of estrogen receptor alpha-mediated AQP7 expression in HepG2 cells
by: Xiaohua Fu, et al.
Published: (2019-12-01)

SENSITIVITY AND SPECIFICITY OF VECTORCARDIOGRAPHY IN DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION COMORBID WITH LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS
by: I. E. Belaya, et al.
Published: (2015-12-01)

Variety of genotypes of a HCV virus and outcomes of chronic hepatitis C: results 5 summer supervision in the territory of the Kirov region
by: S. V. Baramzina, et al.
Published: (2014-09-01)

The experience of the Moscow City Center for AIDS Prevention and Treatment of using glecaprevir/pibrentasvir in patients with HIV/HCV coinfection
by: A. I. Mazus, et al.
Published: (2021-12-01)

Atherogenic dyslipidemia and insulin resistance associated with nonalcohol hepatic steatosis: comparison, contrast, and differentiated therapy
by: L. B. Lazebnik, et al.
Published: (2009-06-01)

Modeling and prediction of foodstuff output based on ε-SVR method
by: DONG Mei-shuang, et al.
Published: (2009-07-01)

Comprehensive Assessment of Indoor Thermal in Vernacular Building Using Machine Learning Model with GAN-Based Data Imputation: A Case of Aceh Region, Indonesia
by: Muslimsyah Muslimsyah, et al.
Published: (2025-07-01)

Combined use of direct antiviral drugs - paritrapevir, ritonavir, ombitasvir and dasabuvir in the treatment of patients with HCV-deterministic compensated cirrhosis in real clinical practice
by: Yu. M. Ambalov, et al.
Published: (2018-06-01)

Novel Polymorphism in a Promoter of MBL2 Gene Result in Lower MBL Expression in Chronic Infection Caused by HCV
by: Paywast Jamal Jalal
Published: (2020-12-01)

Nutritional treatment in patients with cardiovascular diseases, hepatic steatosis and metabolic disorders
by: Fidel Krasniqi, et al.
Published: (2025-06-01)

Acceptability and usability of oral fluid HCV self-testing among health-facility users from Brazil: a cross-sectional study of 685 participants
by: Hugo Perazzo, et al.
Published: (2025-07-01)

Steatosis and Interferon Associated with HBsAg Immune Control in Chronic Hepatitis B: A Real-World Propensity Score-Matched Study
by: Qi Xu, et al.
Published: (2025-06-01)

Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b)
by: P. O. Bogomolov, et al.
Published: (2018-08-01)

Depth-Dependent Variability in Ultrasound Attenuation Imaging for Hepatic Steatosis: A Pilot Study of ATI and HRI in Healthy Volunteers
by: Alexander Martin, et al.
Published: (2025-07-01)